Pharmaceutical Companies

Cara Therapeutics

Country: 🇺🇸United States

Ownership: Public

Established: 2004-07-02

Employees: 55

Market Cap: $19.6M

Website: http://www.caratherapeutics.com

CARA Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors (KORs). Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain. The company was founded by Derek T. Chalmers, Michael E...

Cara Therapeutics

🇺🇸United States

Ownership: Public

Established: 2004-07-02

Employees: 55

Market Cap: $19.6M

Website: http://www.caratherapeutics.com

Minerva Neurosciences

Country: 🇺🇸United States

Ownership: Public

Established: 2007-01-01

Employees: 9

Market Cap: $19.3M

Website: http://www.minervaneurosciences.com

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. It develops Roluperidone for the treatment of negative symptoms in patients with schizophrenia and MIN-301 for the treatment of Parkinson’s disease. The company was founded by Rogerio Vivaldi Coelho and Goeffrey...

Minerva Neurosciences

🇺🇸United States

Ownership: Public

Established: 2007-01-01

Employees: 9

Market Cap: $19.3M

Website: http://www.minervaneurosciences.com

COCRYSTAL PHARMA INC.

Country: 🇺🇸United States

Ownership: Public

Established: 2004-01-01

Employees: 12

Market Cap: $19.2M

Website: http://www.cocrystalpharma.com

COCRYSTAL PHARMA INC.

🇺🇸United States

Ownership: Public

Established: 2004-01-01

Employees: 12

Market Cap: $19.2M

Website: http://www.cocrystalpharma.com

Aprea Therapeutics

Country: 🇺🇸United States

Ownership: Public

Established: -

Employees: 7

Market Cap: $19.1M

Website: http://www.aprea.com

Aprea Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of cancer therapeutics. It is involved in the development and commercialization of novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. The company was founded by Vladimir Bykov, Klas Gota Wiman, Staffan Stromblad, Natalia Issaeva, Galina Selivanova, and Wen Jie Bao in 2002 and is headquart...

Aprea Therapeutics

🇺🇸United States

Ownership: Public

Established: -

Employees: 7

Market Cap: $19.1M

Website: http://www.aprea.com

Lipocine

Country: 🇺🇸United States

Ownership: -

Established: -

Employees: 17

Market Cap: $18.8M

Website: -

Lipocine

🇺🇸United States

Ownership: -

Established: -

Employees: 17

Market Cap: $18.8M

Website: -

Sol-Gel Technologies, Inc.

Country: 🇺🇸United States

Ownership: -

Established: -

Employees: -

Market Cap: $18.5M

Website: -

Sol-Gel Technologies, Inc.

🇺🇸United States

Ownership: -

Established: -

Employees: -

Market Cap: $18.5M

Website: -

CytoMed Therapeutics

Country: 🇸🇬Singapore

Ownership: -

Established: -

Employees: 34

Market Cap: $18.3M

Website: -

CytoMed Therapeutics Ltd. is a biopharmaceutical company, which engages in the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy, and undertaking the research and development of immune cell and stem cell-based therapy. It operates through the Malaysia and Singapore geographical segments. The company was founded by Chee Kong Choo on March 9, 2018 and is headquartered in Singapore.

CytoMed Therapeutics

🇸🇬Singapore

Ownership: -

Established: -

Employees: 34

Market Cap: $18.3M

Website: -

Nymox Pharmaceutical Corp.

Country: 🇨🇦Canada

Ownership: Public

Established: 1989-01-01

Employees: 1

Market Cap: $18.2M

Website: http://www.nymox.com

Nymox Pharmaceutical Corp.

🇨🇦Canada

Ownership: Public

Established: 1989-01-01

Employees: 1

Market Cap: $18.2M

Website: http://www.nymox.com

Synlogic

Country: 🇺🇸United States

Ownership: Public

Established: 2014-01-01

Employees: 6

Market Cap: $17.4M

Website: http://www.synlogictx.com

Synlogic, Inc. is a biopharmaceutical company which engages in the discovery and development of synthetic biotic medicines. It focuses on phenylketonuria, enteric hyperoxaluria, immuno-oncology solid tumors, inflammatory bowel disease, and vaccines and other inflammatory programs. The company was founded by James J. Collins and Timothy K. Lu on December 20, 2007 and is headquartered in Cambridge, MA.